S. E. , G. S. , A. J. Boonen-s, C. R. , C. J. et al., Failure to perceive increased risk of fracture in women 55 years and older : the Global Longitudinal Study of Osteoporosis in Women (GLOW), Osteoporos Int, issue.1, pp.22-27, 2011.

S. E. , H. S. Rosen-c, B. C. , A. J. , and A. T. Silverman-s, Adherence to bisphosphonate therapy and fracture rates in osteoporosic women : relationship to vertebral and nonvertebral fractures from 2 US claims databases, Mayo Clin. Proc, issue.8, pp.81-1013, 2006.

S. M. Zillich-a, P. B. , R. K. Somma-mcgivney, M. A. Pringle-j, and S. R. , Exploring successful community pharmacist-physician collaborative working relationships using mixed methods, Res. Social Adm. Pharm, vol.6, issue.4, pp.307-323, 2010.

S. O. Borgström-f, K. J. , C. J. , C. C. Mccloskey, and E. V. , Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA), Arch. Osteoporos, vol.6, issue.12, pp.59-155, 2011.

T. T. Kaunisvesi-k and . Airaksinen-m, Primary care physicians' perceptions of medication errors and error prevention in cooperation with community pharmacists, Res. Social Adm. Pharm, vol.7, issue.2, pp.162-179, 2011.

. La, la file active sera de 40 patients qui seront suivis jusqu'en 2016 (patients inclus, 2013.

B. Karine, Ostéoporose post-ménopausique et ses enjeux ; Solid'os, 2010.

M. Maravic, L. Bihan, C. Landais, P. Fardellone, and P. , Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005.
DOI : 10.1016/S0020-1383(99)00248-X

J. Jensen and J. Bagger, Long-Term Social Prognosis after Hip Fractures, Acta Orthopaedica Scandinavica, vol.3, issue.1, pp.97-101, 1982.
DOI : 10.1136/bmj.3.5928.456

URL : http://www.tandfonline.com/doi/pdf/10.3109/17453678208992185?needAccess=true

S. Silverman and E. Siris, Adherence to biphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk, J.Bone and Mineral Research, vol.20, 2005.

S. Ross, E. Samuels, K. Gairy, S. Iqbal, and E. Badamgarav, Siris EValue Health. A meta-analysis of osteoporotic fracture risk with medication nonadherence, pp.571-81, 2011.

R. Mickaël and . Service-de-rhumatologie, Hôpital Saint-Antoine (APHP), Paris, Education thérapeutique et ostéoporose, 2011.

V. Rabenda, J. Register, and A. Scheen, Prévention et traitement de l'ostéoporose: éviter l'inertie clinique et motiver l'adhésion au traitement, Rev Med Liège, vol.65, pp.5-6, 2010.

D. Prévention and . Et-traitement-de-l-'ostéoporose, Note de synthèse HAS, juillet, 2006.

D. Weycker, D. Macarios, J. Edelsberg, and G. Oster, Compliance with drug therapy for postmenopausal osteoporosis, Osteoporosis International, vol.42, issue.8, pp.1645-52, 2006.
DOI : 10.7326/0003-4819-132-11-200006060-00026

G. Rajzbaum, La prise en charge de l'ostéoporose après fracture de basse énergie : l'intérêt des filières en milieu hospitalier. Réalités en rhumatologie, 41, janv, pp.4-9, 2012.

D. Marsh, K. Akesson, D. Beaton, E. Bogoch, S. Boonen et al., Coordinator-based systems for secondary prevention in fragility fracture patients, Osteoporosis International, vol.7, issue.2, pp.2051-65, 2011.
DOI : 10.1007/s00198-002-1336-5

R. Dell and D. Greene, Is osteoporosis disease management cost effective? Curr Osteoporos Rep, pp.49-55, 2010.
DOI : 10.1007/s11914-010-0009-0

A. Mclellan, S. Wolowacz, E. Zimovetz, S. Beard, S. Lock et al., Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8??years of service provision, Osteoporosis International, vol.3, issue.4, pp.2083-98, 2011.
DOI : 10.1383/wohm.2006.3.4.149

N. Schmitt, J. Schmitt, and M. Dören, The role of physical activity in the prevention of osteoporosis in postmenopausal women???An update, Maturitas, vol.63, issue.1, pp.34-42, 2009.
DOI : 10.1016/j.maturitas.2009.03.002

V. Rabenda, J. Register, and A. Scheen, Prévention et traitement de l'ostéoporose: éviter l'inertie clinique et motiver l'adhésion au traitement, Rev Med Liège, vol.65, pp.5-6358, 2010.

K. Martin, Y. J. Campbell, H. Abarca, J. White, and T. , Analysis of the Comparative Effectiveness of 3 Oral Bisphosphonates in a Large Managed Care Organization: Adherence, Fracture Rates, and All-Cause Cost, Journal of Managed Care Pharmacy, vol.17, issue.8, pp.596-609, 2011.
DOI : 10.18553/jmcp.2011.17.8.596

J. Jensen and J. Bagger, Long-Term Social Prognosis after Hip Fractures, Acta Orthopaedica Scandinavica, vol.3, issue.1, pp.97-101, 1982.
DOI : 10.1136/bmj.3.5928.456

URL : http://www.tandfonline.com/doi/pdf/10.3109/17453678208992185?needAccess=true